Halcyon Medical Overview
- Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Halcyon Medical General Information
Description
Provider of healthcare services intended to offer cardiovascular treatment. The company's services are focused on the treatment of heart and other related diseases with advanced therapeutic methods, enabling patients to get efficient treatment for their diseases and recover faster.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 21771 Stevens Creek Boulevard
- Suite 100
- Cupertino, CA 95014
- United States
+1 (650) 000-0000
Halcyon Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Jan-2020 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 30-Apr-2014 | Completed | Startup |
Halcyon Medical Patents
Halcyon Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170095291-A1 | Aorticorenal ganglion detection | Abandoned | 06-Oct-2015 | 00000000000 | 00 |
| US-20180177549-A1 | Aorticorenal ganglion detection | Abandoned | 06-Oct-2015 | 00000000000 | 0 |
| EP-3397334-A1 | Aorticorenal ganglion detection | Withdrawn | 06-Oct-2015 | 00000000000 | |
| EP-3397334-A4 | Aorticorenal ganglion detection | Withdrawn | 06-Oct-2015 | A61B18/1492 | 0 |
Halcyon Medical Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Douglas Harrington | Founder, Chief Executive Officer & President |